# CBLL (CeriBell, Inc.) - SEC EDGAR Financial Statements

> CeriBell, Inc. reported $108.7M in revenue and a net loss of $73.88M for the trailing twelve months ended September 30, 2026 (up 29.9% year over year), with a 89.3% gross margin and a -69.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/CBLL
- Markdown: https://convexityos.com/fundamentals/CBLL.md
- SEC CIK: 0001861107
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:29 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001861107&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $108.7M | +29.9% YoY |
| Operating Income | TTM | -$75.87M | -69.8% margin |
| Net Income | TTM | -$73.88M | -68.0% net margin |
| Diluted EPS | TTM | -$1.92 | Split-adjusted |
| Free Cash Flow | TTM | -$56.43M | -51.9% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $117.5M | Total debt: $1.65M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Revenue** | $89.06M | $65.44M | $45.23M |
| Cost of Revenue | $10.79M | $8.69M | $7.06M |
| **Gross Profit** | $78.27M | $56.75M | $38.16M |
| Research & Development | $19.14M | $13.56M | $8.99M |
| Selling, General & Admin | $117.5M | $82.90M | $59.21M |
| Total Operating Expenses | $136.7M | $96.46M | $68.20M |
| **Operating Income** | -$58.40M | -$39.71M | -$30.04M |
| **EBITDA** | -$57.06M | -$38.57M | -$29.19M |
| Interest Expense | $1.89M | $1.99M | $2.10M |
| Income Before Tax | -$53.41M | -$40.45M | -$29.45M |
| Income Tax Expense | $0 | $0 | $11K |
| **Net Income** | -$53.41M | -$40.45M | -$29.46M |
| Basic EPS | -$1.46 | -$3.39 | -$5.56 |
| **Diluted EPS** | -$1.46 | -$3.39 | -$5.56 |
| Basic Shares Outstanding | 36.5M | 11.9M | 5.3M |
| Diluted Shares Outstanding | 36.5M | 11.9M | 5.3M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $29.34M | $28.10M | $26.49M | $24.78M | $22.59M | $21.20M | $20.49M | $18.53M |
| Cost of Revenue | $3.00M | $2.16M | $3.37M | $3.14M | $2.65M | $2.52M | $2.48M | $2.30M |
| **Gross Profit** | $26.34M | $25.94M | $23.12M | $21.64M | $19.94M | $18.68M | $18.01M | $16.24M |
| Research & Development | $7.40M | $6.75M | $6.16M | $5.06M | $4.98M | $4.85M | $4.25M | $3.91M |
| Selling, General & Admin | $39.48M | $39.17M | $37.71M | $31.18M | $29.61M | $28.78M | $27.97M | $25.21M |
| Total Operating Expenses | $46.89M | $45.92M | $43.87M | $36.24M | $34.59M | $33.63M | $32.21M | $29.12M |
| **Operating Income** | -$20.55M | -$19.98M | -$20.75M | -$14.60M | -$14.65M | -$14.95M | -$14.21M | -$12.88M |
| **EBITDA** | -$20.30M | -$19.74M | -$20.51M | -$14.30M | -$14.26M | -$14.63M | -$13.87M | -$12.52M |
| Interest Expense | $267K | $438K | $434K | $462K | $480K | $477K | $471K | $499K |
| Income Before Tax | -$21.35M | -$19.27M | -$19.74M | -$13.53M | -$13.46M | -$13.64M | -$12.78M | -$12.58M |
| Income Tax Expense | $0 | $0 | -- | -- | $0 | $0 | -- | -- |
| **Net Income** | -$21.35M | -$19.27M | -$19.74M | -$13.53M | -$13.46M | -$13.64M | -$12.78M | -$12.58M |
| Basic EPS | -$0.55 | -$0.51 | -$0.52 | -- | -$0.37 | -$0.38 | -$0.36 | -- |
| **Diluted EPS** | -$0.55 | -$0.51 | -$0.52 | -- | -$0.37 | -$0.38 | -$0.36 | -- |
| Basic Shares Outstanding | 38.5M | 38.0M | 37.7M | -- | 36.8M | 36.3M | 35.9M | -- |
| Diluted Shares Outstanding | 38.5M | 38.0M | 37.7M | -- | 36.8M | 36.3M | 35.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $40.48M | $194.4M | $34.49M |
| Short-Term Investments | $118.8M | -- | -- |
| **Cash & Short-Term Investments** | $159.3M | $194.4M | $34.49M |
| Accounts Receivable, Net | $15.05M | $10.88M | $7.96M |
| Inventory | $7.29M | $6.94M | $5.87M |
| **Total Current Assets** | $186.7M | $217.3M | $51.96M |
| Property, Plant & Equipment, Net | $2.03M | $2.31M | $1.58M |
| Other Non-Current Assets | $2.91M | $2.19M | $1.98M |
| **Total Non-Current Assets** | $9.09M | $8.14M | $6.96M |
| **Total Assets** | $195.8M | $225.4M | $58.92M |
| Accounts Payable | $2.84M | $1.14M | $732K |
| Deferred Revenue (Current) | $101K | $97K | $206K |
| Other Current Liabilities | $818K | $609K | $595K |
| **Total Current Liabilities** | $19.19M | $12.99M | $21.60M |
| Deferred Revenue (Non-Current) | $0 | $30K | $44K |
| Other Non-Current Liabilities | $106K | $356K | $441K |
| **Total Non-Current Liabilities** | $21.28M | $21.26M | $2.16M |
| **Total Liabilities** | $40.47M | $34.25M | $23.76M |
| **Total Debt (incl. Leases)** | $2.46M | $2.40M | $2.37M |
| Common Stock | $38K | $36K | $5.0K |
| Retained Earnings | -$220.4M | -$166.9M | -$126.5M |
| Accumulated Other Comp. Income | $159K | -- | -- |
| **Total Stockholders' Equity** | $155.3M | $191.2M | -$112.3M |
| Total Equity | $155.3M | $191.2M | -$112.3M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $41.99M | $32.66M | $45.25M | $40.48M | $23.74M | $40.14M | $153.4M | $194.4M |
| Short-Term Investments | $75.48M | $96.60M | $95.93M | $118.8M | $144.8M | $137.3M | $29.34M | -- |
| **Cash & Short-Term Investments** | $117.5M | $129.3M | $141.2M | $159.3M | $168.5M | $177.4M | $182.7M | $194.4M |
| Accounts Receivable, Net | $17.79M | $15.99M | $15.71M | $15.05M | $12.23M | $12.31M | $11.30M | $10.88M |
| Inventory | $6.96M | $6.74M | $6.90M | $7.29M | $6.02M | $6.00M | $6.55M | $6.94M |
| **Total Current Assets** | $147.4M | $157.8M | $168.9M | $186.7M | $191.8M | $199.8M | $205.4M | $217.3M |
| Property, Plant & Equipment, Net | $1.77M | $1.76M | $1.93M | $2.03M | $2.06M | $2.10M | $2.12M | $2.31M |
| Other Non-Current Assets | $4.14M | $3.42M | $3.46M | $2.91M | $2.44M | $2.48M | $2.28M | $2.19M |
| **Total Non-Current Assets** | $8.93M | $8.50M | $9.17M | $9.09M | $7.72M | $7.90M | $8.05M | $8.14M |
| **Total Assets** | $156.4M | $166.3M | $178.1M | $195.8M | $199.5M | $207.7M | $213.5M | $225.4M |
| Accounts Payable | $2.33M | $3.19M | $1.98M | $2.84M | $2.18M | $2.44M | $1.37M | $1.14M |
| Deferred Revenue (Current) | $230K | $11K | $88K | $101K | $136K | $216K | $202K | $97K |
| Other Current Liabilities | $193K | $343K | $413K | $818K | $766K | $785K | $841K | $609K |
| **Total Current Liabilities** | $18.03M | $17.20M | $16.18M | $19.19M | $15.17M | $15.01M | $11.83M | $12.99M |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | $3.0K | $7.0K | $12K | $30K |
| Other Non-Current Liabilities | $367K | $106K | $106K | $106K | $106K | $106K | $106K | $356K |
| **Total Non-Current Liabilities** | $20.80M | $20.84M | $21.08M | $21.28M | $20.28M | $20.52M | $20.76M | $21.26M |
| **Total Liabilities** | $38.83M | $38.03M | $37.27M | $40.47M | $35.44M | $35.53M | $32.59M | $34.25M |
| **Total Debt (incl. Leases)** | $1.65M | $1.93M | $2.20M | $2.46M | $1.60M | $1.87M | $2.14M | $2.40M |
| Common Stock | $39K | $39K | $38K | $38K | $38K | $37K | $36K | $36K |
| Retained Earnings | -$280.7M | -$259.4M | -$240.1M | -$220.4M | -$206.8M | -$193.4M | -$179.7M | -$166.9M |
| Accumulated Other Comp. Income | -$143K | -$92K | $18K | $159K | $139K | $5.0K | -$6.0K | -- |
| **Total Stockholders' Equity** | $117.5M | $128.3M | $140.8M | $155.3M | $164.1M | $172.2M | $180.9M | $191.2M |
| Total Equity | $117.5M | $128.3M | $140.8M | $155.3M | $164.1M | $172.2M | $180.9M | $191.2M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | -$53.41M | -$40.45M | -$29.46M |
| Depreciation & Amortization | $1.34M | $1.14M | $847K |
| Stock-Based Compensation | $12.22M | $5.41M | $2.68M |
| Change in Receivables | -$4.17M | -$2.92M | -$2.66M |
| Change in Inventory | -$351K | -$1.07M | -$1.79M |
| Change in Payables | $1.75M | $250K | $309K |
| **Operating Cash Flow** | -$40.81M | -$35.04M | -$29.16M |
| Capital Expenditure | -$767K | -$1.34M | -$983K |
| **Free Cash Flow** | -$41.58M | -$36.38M | -$30.14M |
| Purchases of Investments | -$210.8M | $0 | -- |
| **Investing Cash Flow** | -$118.1M | -$1.60M | -$1.76M |
| **Financing Cash Flow** | $5.05M | $196.5M | -$2.82M |
| **Net Change in Cash** | -$153.9M | $159.9M | -$33.74M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$21.35M | -$19.27M | -$19.74M | -$13.53M | -$13.46M | -$13.64M | -$12.78M | -$12.58M |
| Depreciation & Amortization | $249K | $245K | $239K | $291K | $391K | $324K | $335K | $364K |
| Stock-Based Compensation | $7.10M | $6.00M | $3.72M | $3.36M | $3.35M | $3.17M | $2.35M | $2.20M |
| Change in Receivables | -$1.80M | -$283K | -$659K | -$2.82M | $78K | -$1.01M | -$421K | -$905K |
| Change in Inventory | -$217K | $164K | $386K | -$1.26M | -$24K | $554K | $383K | -$27K |
| Change in Payables | -$850K | $1.26M | -$857K | $589K | -$205K | $1.02M | $345K | -$903K |
| **Operating Cash Flow** | -$13.08M | -$12.86M | -$19.30M | -$10.77M | -$11.10M | -$7.53M | -$11.40M | -$9.97M |
| Capital Expenditure | -$100K | -$17K | -$125K | -$179K | -$369K | -$71K | -$148K | -$357K |
| **Free Cash Flow** | -$13.18M | -$12.88M | -$19.42M | -$10.95M | -$11.47M | -$7.60M | -$11.55M | -$10.33M |
| Purchases of Investments | -$12.72M | -$48.88M | -$26.73M | -$22.04M | -$45.98M | -$113.5M | -$29.33M | -- |
| **Investing Cash Flow** | $20.82M | -$606K | $22.44M | $26.11M | -$6.94M | -$107.7M | -$29.61M | -$493K |
| **Financing Cash Flow** | $1.58M | $880K | $1.63M | $1.40M | $1.64M | $2.01M | $2.0K | $190.7M |
| **Net Change in Cash** | $9.33M | -$12.59M | $4.78M | $16.74M | -$16.40M | -$113.2M | -$41.01M | $180.3M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Gross Margin** | 87.9% | 86.7% | 84.4% |
| **Operating Margin** | -65.6% | -60.7% | -66.4% |
| **Net Profit Margin** | -60.0% | -61.8% | -65.1% |
| Return on Equity (ROE) | -34.4% | -21.2% | -- |
| Return on Assets (ROA) | -27.3% | -17.9% | -50.0% |
| Current Ratio | 9.73x | 16.73x | 2.41x |
| Quick Ratio | 9.35x | 16.19x | 2.13x |
| Debt to Equity | 0.02x | 0.01x | -- |
| **Revenue Growth (YoY)** | +36.1% | +44.7% | -- |
| Gross Profit Growth (YoY) | +37.9% | +48.7% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 89.3% | 88.9% | 87.7% | 87.9% | 88.0% | 87.8% | 87.3% | 86.7% |
| **Operating Margin** | -69.8% | -68.6% | -68.3% | -65.6% | -68.5% | -67.1% | -63.6% | -60.7% |
| **Net Profit Margin** | -68.0% | -64.7% | -63.5% | -60.0% | -63.3% | -63.8% | -62.5% | -61.8% |
| Return on Equity (ROE) | -62.9% | -51.4% | -42.9% | -34.4% | -32.0% | -28.7% | -24.7% | -21.2% |
| Return on Assets (ROA) | -47.2% | -39.7% | -33.9% | -27.3% | -26.3% | -23.8% | -20.9% | -17.9% |
| Current Ratio | 8.18x | 9.18x | 10.44x | 9.73x | 12.65x | 13.31x | 17.36x | 16.73x |
| Quick Ratio | 7.79x | 8.79x | 10.01x | 9.35x | 12.25x | 12.91x | 16.81x | 16.19x |
| Debt to Equity | 0.01x | 0.02x | 0.02x | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x |
| **Revenue Growth (YoY)** | +29.9% | +32.5% | +29.3% | +33.7% | +31.4% | +38.4% | +42.3% | -- |
| Gross Profit Growth (YoY) | +32.1% | +38.8% | +28.4% | +33.3% | +32.8% | +42.0% | +45.9% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
